Business Segments · Goodwill
North American Pharmaceutical — Goodwill
McKesson North American Pharmaceutical — Goodwill increased by 0.7% to $2.80B in Q4 2025 compared to the prior quarter.
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ1 2025
Last reportedQ4 2025
Rolls up toGoodwill
How to read this metric
A stable or growing balance indicates successful integration and value retention, while a sudden decrease suggests impairment due to poor performance.
Detailed definition
This metric represents the intangible asset value recorded on the balance sheet for the North American Pharmaceutical se...
Peer comparison
Standard balance sheet item for companies that grow through M&A, comparable across all sectors.
Metric ID:
mck_segment_north_american_pharmaceutical_goodwillHistorical Data
3 periods
| Q1 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|
| Value | $2.74B | $2.78B | $2.80B |
| QoQ Change | — | +1.6% | +0.7% |
Range$2.74B – $2.80B
Current Streak2+ quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is McKesson's north american pharmaceutical — goodwill?
- McKesson (MCK) reported north american pharmaceutical — goodwill of $2.80B in Q4 2025.
- What does north american pharmaceutical — goodwill mean?
- The total value of goodwill attributed to the North American Pharmaceutical segment from past acquisitions.